规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | AS1949490 is a highly potent, orally bioavailable inhibitor of SHIP2 phosphatase, displaying IC50 values of 0.34 and 0.62 µM against Mouse and Human SHIP2, respectively. Its selectivity profile shows significantly weaker activity against Human SHIP1, PTEN, synaptojanin, and myotubularin, with no inhibitory effect observed at concentrations above 50 µM for these enzymes. AS1949490 enhances the phosphorylation of Akt, leading to increased glucose consumption and uptake, thereby activating the intracellular insulin signaling pathways. This mechanism underlines its potential utility in diabetes research[1].[2]. |
Animal study | In diabetic mice, oral administration of AS1949490 at 300 mg/kg, twice daily for 7 or 10 days, lowers plasma glucose levels and activates intracellular insulin signaling. When given once at 300 mg/kg for 8 hours to male ICR mice, the compound suppresses gluconeogenesis and the expression of genes associated with this metabolic pathway[1]. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.69mL 0.54mL 0.27mL |
13.45mL 2.69mL 1.34mL |
26.89mL 5.38mL 2.69mL |
CAS号 | 1203680-76-5 |
分子式 | C20H18ClNO2S |
分子量 | 371.88 |
SMILES Code | ClC1=CC=C(C=C1)COC2=C(SC=C2)C(N[C@@H](C)C3=CC=CC=C3)=O |
MDL No. | MFCD18086887 |
别名 | |
运输 | 蓝冰 |
InChI Key | RFZPGNRLOKVZJY-AWEZNQCLSA-N |
Pubchem ID | 44473434 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry, 2-8°C |
溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|